BIG 02/98 Docetaxel - Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Doxorubicine + docetaxel sequential|DRUG: doxorubicine + cyclophosphamide sequential|DRUG: doxorubicine + cyclophosphamide combined|DRUG: doxorubicine + docetaxel combined
Sponsor: Sanofi